Immuneering Corporation (IMRX) Tops Q3 EPS by 3c

Immuneering Corporation (NASDAQ: IMRX) reported Q3 EPS of ($0.38), $0.03 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• AT&T closes sale of floating rate notes totaling $2.3B
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low